Ralf Weiskirchen
Weiskirchen, Ralf 1964-
VIAF ID: 60003328 (Personal)
Permalink: http://viaf.org/viaf/60003328
Preferred Forms
- 100 0 _ ‡a Ralf Weiskirchen
- 100 1 _ ‡a Weiskirchen, Ralf ‡d 1964-
- 100 1 _ ‡a Weiskirchen, Ralf ‡d 1964-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
All You Can Feed: Some Comments on Production of Mouse Diets Used in Biomedical Research with Special Emphasis on Non-Alcoholic Fatty Liver Disease Research | |
Editorial: Liver Myofibroblasts | |
Elevated CTRP1 Plasma Concentration Is Associated with Sepsis and Pre-Existing Type 2 Diabetes Mellitus in Critically Ill Patients | |
Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation | |
Endoglin in human liver disease and murine models of liver fibrosis a protective factor against liver fibrosis | |
Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on -Glycosylation | |
Established liver cell lines: are you sure to have the right ones? | |
Exercise-Induced Release of Pharmacologically Active Substances and Their Relevance for Therapy of Hepatic Injury | |
Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease | |
The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells | |
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury | |
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection | |
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis | |
Die genetische Deletion des von Thrombozyten sezernierten Chemokins PF4 | |
hepatic lipidome From basic science to clinical translation | |
The hepatic microenvironment essentially determines tumor cell dormancy and metastatic outgrowth of pancreatic ductal adenocarcinoma. | |
Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step | |
hop constituent xanthohumol exhibits hepatoprotective effects and inhibits the activation of hepatic stellate cells at different levels | |
Identification of Pparγ-modulated miRNA hubs that target the fibrotic tumor microenvironment | |
Impact of a Nitric Oxide Synthase Inhibitor (L-NAME) on Ischemia?Reperfusion Injury of Cholestatic Livers by Pringle Maneuver and Liver Resection after Bile Duct Ligation in Rats | |
The impact of TGF-β and S1P on the cellular localization of the LIM domain proteins CRP2 and FHL2 in LX-2 cells | |
The impact of the reactive oxygen species scavenger N-acetyl-L-cysteine for PDGF-BB signaling in cultured hepatic stellate cells | |
The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH) | |
Inhibitory T Cell Receptors PD1 and 2B4 Are Differentially Regulated on CD4 and CD8 T Cells in a Mouse Model of Non-alcoholic Steatohepatitis | |
Insights in Gastrointestinal and hepatic pharmacology: 2021 | |
The interesting case-orphan diseases-double trouble | |
Intestinal Wnt in the transition from physiology to oncology | |
Isolation of Bovine and Human Milk Extracellular Vesicles | |
Isolation of Mature (Peritoneum-Derived) Mast Cells and Immature (Bone Marrow-Derived) Mast Cell Precursors from Mice | |
Der Komplementfaktor 5 (C5) beeinflusst die Fibrose-Suszeptibilität im Inzuchtmausmodell | |
Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells | |
Lipocalin 2, ein Schlüsselregulator der Leberhomeostase im Rahmen einer durch Methionin-Cholin-defizienter Diät erzeugten nichtalkoholischen Steatohepatitis (NASH) in der Maus | |
Lipocalin 2 in perpetuating hepatic lipid homeostasis challenged by high fructose diet | |
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy | |
Magnetic-Assisted Treatment of Liver Fibrosis | |
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. | |
Mechanisms Underlying Cell Therapy in Liver Fibrosis An Overview | |
The megalin/gp330 receptor is involved in the capability of hepatic stellate cells to bind and internalize vitamin D binding protein (Gc-globulin) | |
The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis | |
The murine latent transforming growth factor-β binding protein (Ltbp-1) is alternatively spliced, and maps to a region syntenic to human chromosome 2p21–22 | |
A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and antimesangioproliferative effects. | |
Die PDGF-BB-vermittelte Stimulation Hepatischer Sternzellen wird in vitro durch die Plasmaprotease FSAP (Faktor VII Aktivierende Protease) inhibiert | |
The PDGF system and its antagonists in liver fibrosis | |
Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1 | |
Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma | |
Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview | |
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts | |
Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease | |
role of CCR2+ macrophages for angiogenesis and tumorvascularization in fibrotic livers | |
The role of PDGF-D in healthy and fibrotic kidneys. | |
Severity assessment in mice subjected to carbon tetrachloride | |
Short-term western diet aggravates non-alcoholic fatty liver disease (NAFLD) with portal hypertension in TGR(mREN2)27 rats | |
Structure of mammalian plasma fetuin-B and its mechanism of selective metallopeptidase inhibition | |
Studies of the cytokine-induced regulation and the biological functions of Lipocalin-2 in human prostate cancer cell lines | |
Sublethal necroptosis signaling promotes inflammation and liver cancer | |
Targeted disruption of the mouse Csrp2 gene encoding the cysteine- and glycine-rich LIM domain protein CRP2 result in subtle alteration of cardiac ultrastructure | |
Targeting Activated Hepatic Stellate Cells Using Collagen-Binding Chitosan Nanoparticles for siRNA Delivery to Fibrotic Livers | |
Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases | |
TIMP-1 überexprimierende Leberzellen zeigen mittels DIGE-Technologie ein verändertes Proteinmuster mit Fibrose-relevanten Proteinen | |
TNF-α controls Lipocalin-2 expression in PC-3 prostate cancer cells | |
TNFR1 determines progression of chronic liver injury in the IKKγ/Nemo genetic model | |
Trace metal imaging in diagnostic of hepatic metal disease | |
Transcriptional Targeting of Activated Hepatic Stellate Cells by Modular Promoter Fragments | |
Transdifferenzierungsabhängige Expression von Spleißvarianten des Transkriptionsfaktors „Serum Response Factor“ in aktivierten hepatischen Sternzellen | |
Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of Cdkn2a/Arf expression | |
Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection | |
Transiente Proliferation und Aktivierung Hepatischer Sternzellen im Maus-Modell der Thioacetamid induzierten Fibrose | |
Tumor Necrosis Factor-α (TNFα) Stimulates Triple-Negative Breast Cancer Stem Cells to Promote Intratumoral Invasion and Neovasculogenesis in the Liver of a Xenograft Model | |
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations | |
Untersuchungen zur zytokin-induzierten Regulierung und den biologischen Funktionen von Lipocalin-2 in humanen Prostatakrebs-Zelllinien | |
An unusual melting curve profile in LightCycler multiplex genotyping of the hemochromatosis H63D/C282Y gene mutations | |
Update on hepatic stellate cells: pathogenic role in liver fibrosis and novel isolation techniques | |
An update on the recent advances in antifibrotic therapy | |
Upregulation of human acyl-CoA synthetase 5 in fatty liver degeneration sensitizes for hepatocellular apoptosis | |
Usage of Mitogen-Activated Protein Kinase Small Molecule Inhibitors: More Than Just Inhibition! | |
Validation of connective tissue growth factor (CTGF/CCN2) and its gene polymorphisms as noninvasive biomarkers for the assessment of liver fibrosis | |
Variable expression of cystatin C in cultured trans-differentiating rat hepatic stellate cells | |
Visfatin Serum Levels Predict Mortality in Critically Ill Patients | |
Visualization of the therapeutic efficacy of a gene correction approach in Wilson's disease by laser-ablation inductively coupled mass spectrometry. | |
Vitamin A too good to be bad? | |
What Does the "AKT" Stand for in the Name "AKT Kinase"? Some Historical Comments | |
When sleeping beauty wakes up and jumps into a cancer-minded environment | |
Wilson disease: more complex than just simply a copper overload condition?—a narrative review | |
Zinc supplementation augments TGF-β1-dependent regulatory T cell induction | |
α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin | |
자가포식 모니터링을 위한 분석법의 사용 및 해석에 대한 지침(4판) |